Clinical Trial Update: Trofosfamide Versus Adriamycin in Elderly Patients With Soft Tissue Sarcoma (STS) [Phase 2]

View source ↗

Summary

A phase 2 trial comparing trofosfamide to Adriamycin in elderly patients with soft tissue sarcoma; the current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Adriamycin (doxorubicin)
• Trofosfamide (trofosfamide)

Snippet

Sponsor: University Hospital Schleswig-Holstein | Conditions: Sarcoma, Soft Tissue | Phase 2 | Status: UNKNOWN